$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 홍삼의 약리와 독성 기전에 대한 고찰
Review of Red Ginseng in terms of Mechanisms for Pharmacodynamics and Toxicity 원문보기

大韓韓醫學會誌 = Journal of Korean Oriental Medicine, v.33 no.3, 2012년, pp.200 - 230  

박영철 (대구가톨릭대학교 GLP 센터) ,  임정대 (강원대학교 생약자원개발학과) ,  김종봉 (대구가톨릭대학교 의생명과학과) ,  이선동 (상지대학교 한의과대학 예방의학교실)

Abstract AI-Helper 아이콘AI-Helper

Objectives: Ginseng, Panax ginseng C. A., white ginseng, has been used for thousands of years in Traditional Korean Medicine. Red ginseng can be made by a steaming process of white ginseng changing a variety of ginsenosides and ingredients such as dencichine. This article reviews red ginseng for mec...

Keyword

질의응답

핵심어 질문 논문에서 추출한 답변
인삼은 어떻게 분류하는가? Meyer이다. 인삼은 크게 수삼, 백삼과 홍삼으로 분류된다. 수삼은 밭에서 수확한 생인삼으로 70-80%의 수분을 함유한 것이다.
양약의 acetaminophen 역시 간독성 문제가 대두되어 오늘날 용량조절의 문제가 제시되고 있는 이유는 무엇인가? 또한 양약의 acetaminophen 역시 간독성 문제가 대두되어 오늘날 용량조절의 문제가 제시되고 있다. 이것도 간독성의 핵심 기전인 활성중간대사체의 생성 때문이다. 일반적으로 한약 및 양약의 독성이 생체전환을 통한 활성중간대사체 생성에 기인하는데 모든 독성물질의 80%이상이 이에 의한 독성기전으로 설명된다.
세계적으로 널리 알려져 있는 7가지의 인삼속 식물 중 약용으로 이용되는 것은 무엇인가? 세계적으로 널리 알려져 있는 7가지의 인삼속 식물 중 약용으로 이용되는 것은 Panax ginseng C. A. Meyer(고려인삼), Panax japonicum C. A. Meyer(죽절삼), Panax notoginseng (Burk) F.H Chen(전칠삼), Panax quinquefolium L.(화기삼)의 4종이다. 일반적으로 한약으로 이용되는 인삼은 Panax ginseng C.
질의응답 정보가 도움이 되었나요?

참고문헌 (66)

  1. Korean ginseng. 2012. Available at:URL:http://w ww.ko.wikipedia.org/wiki/red ginseng. Accessed June 3, 2012. 

  2. Cheng LQ, Na JR, Bang MH, Kim MK, Yang DC. Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514. Phytochemistry. 2008;69:218-224. 

  3. Hong HD, Kim YC, Rho J, Kim KT. Changes on Physicochemical Properties of Panax ginseng C. A. Meyer during Repeated Steaming Process. J. Ginseng Res. 2007;31(4):222-229. 

  4. Nam KY. The comparative understanding between Red ginseng and White ginsengs, Processed ginsengs(Panax ginseng C.A. Meyer). J. Jinseng Res. 2005;29(1):1-18. 

  5. Shi S, Wang CZ, Tong R, Li X, Fishbein A. Effects of steaming the root of Panax notoginseng on chemical composition and anticancer activities, Food Chemistry. 2010; 118:307-307. 

  6. Liu M, Zhang JT. Protective effects of ginsenoside Rb1 and Rg1 on cultured hippocampal neurons. Yao Xue Xue Bao. 1995;674-678. 

  7. Kim YC, Kim SR, Markelonis GJ, Oh TH. Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. Journal of Neuroscience Research. 1998;53:426-432. 

  8. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, et al. Open-channel block of N-methyl-d-aspartate(NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience. 1992;12:4427-4436. 

  9. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, et al.. Involvement of caspases in proteolytic cleavage of Alzheimer"s amyloid-beta precursor protein and amyloido genic A beta peptide formation. Cell. 1999;97:395-406. 

  10. Na L, Bin L, Dean E. Dluzen YJ. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. Journal of Ethnopharmacology. 2007;111: 458-463. 

  11. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin, AL, Bahr BA, et al.. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia- ischemia: a mechanism of "pathological apoptosis"? Journal of Biological Chemistry. 2001;276:10191-10198. 

  12. Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. Journal of Ethnopharmacology. 2008; 115:441-448. 

  13. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299. 

  14. Morrison RS, Wenzel HJ, Kinoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. Journal of Neuroscience. 1996;16:1337-1345. 

  15. Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M, et al. Inhibitory of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res. 1996;87:357-362. 

  16. Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 2000;67:1297-1306. 

  17. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside- Rb2, 20 (R) - and 20 (R) -ginsenoside- Rg3, of Red ginseng. Biol Pharm Bull. 1995; 18:1197-202. 

  18. Tao H, Yao M, Zou S, Zhao D, Qiu H. Effect of angiogenesis inhibitor Rg3 on the growth and metastasis of gastric cancer in SCID mice. Zhounghua Wai Ke Za Zhi. 2002;40:606-608. 

  19. Yun TK, Lee YS, Lee YH, Kim SI, Yun HY. Anticarcinogenic effect of Panax ginseng C A. Meyer and identification of active compounds. J Korean Med Sci. 2001;16:S6-18. 

  20. Yue YK, Daisy YL, Wong PK. Wu PY, Leung NK, Mak HW, et al. The angiosuppressive effects of 20(R)- ginsenoside Rg3 Biochemical pharmacology, 2006;72:437-445. 

  21. Bocchino M, Marruchella A, Saltini C. Immunogenetics of severe respiratory infections: models for the development of new therapeutic strategies. Respiration. 2005;72:449-457. 

  22. Johnson LN, Koval M. Cross-talk between pulmonary injury, oxidant stress, and gap junctional communication. Antioxid Redox Signal. 2009; 11:355-367. 

  23. Herold S, Tabar TS, Janssen H, Hoegner K, Cabanski M, Lewe-Schlosser P, et al. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in Gram-negative pneumonia. Am J Respir Crit Care Med. 2011; 183:1380-1390. 

  24. Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus. 2005;14: 646-651. 

  25. Lele RD. Beyond reverse pharmacology: mechanism- based scereening of ayurvedic drugs, Journal of Ayurveda & Integrative Medicine. 2010;1(4):257-265. 

  26. Kim TW, Joh EH, Kim B, Kim DH. Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor- 4 on macrophages, international Immunopharmacology. 2012;12:110-116. 

  27. Niu J, Kolattukudy PE. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Science. 2009;117:95- 

  28. Ashida N, Arai H, Yamasaki M, Kita T. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J Biol Chem. 2001;276:16555-16560. 

  29. Choi YJ, Yoon JH, Cha SW, Lee SG. Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway. Fitoterapia. 2011;82:911-919. 

  30. Weisz A. Estrogen stimulates transcription of c-jun protooncogene. Mol Endocrinol. 1990;4: 1041-1050. 

  31. Lin CY. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004;5(9):R66. 

  32. White TE, Gasiewicz TA. The human estrogen receptor structural gene contains a DNA sequence that binds activated mouse and human Ah receptors: a possible mechanism of estrogen receptor regulation by 2,3,7,8-tetrachlorodibenzopdioxin, Biochem Biophys Res Commun. 1993; 193:956-962. 

  33. Lee YJ, Jin YR, Lim WC, Ji SM, Choi S, Jang S, et al. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. Journal of Steroid Biochemistry & Molecular Biology. 2003;84:463-468. 

  34. Kim SY, Jung SH, Kim HS. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun. 2005;337:510-516. 

  35. Laurent M, Martinerie C, Thibout H, Hoffman MP, Verrecchia F, Le Bouc Y, et al. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism. FASEB J. 2003;17:1919-1921. 

  36. Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, et al. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002;16: 555-564. 

  37. Kim SY, Kim DH, Han SJ, Hyun JW, Kim JS. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells. Expression biochemical pharmacology. 2007; 74:1642-1651. 

  38. Oh JI, Chun KH, Joo SH, Oh YT, Lee SK. Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP- 1 cells. Cancer Letters. 2005;230:228-238. 

  39. Gregoire FM, Smas CM , Sul HS. Understanding adipocyte differentiation. Physiol. Rev. 1998;78: 783-809. 

  40. Ericsson J, Jackson SM, Kim JB, Spiegelman BM. Edwards PA. Identification of glycerol- 3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory elementbinding protein-responsive gene. J. Biol. Chem. 1997;272:7298- 7305. 

  41. Ron FM, Stephen RF. Hormonal Signaling and Transcriptional Control of Adipocyte Differentiation. The journal of nutrition. 2000: supplement:3111S-3121S. 

  42. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, Jiang A, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice, Diabetes. 2006;55: 2180-2191. 

  43. Lin CL, Huang HC, Lin JK. Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J. Lipid Res. 2007;Epub ahead of print. 

  44. Fryer LG, Parbu-Patel A, Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways, J. Biol. Chem. 2002; 277:25226-25232. 

  45. Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, Kim MJ, et al.. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte Biochemical and Biophysical Research Communications. 2007;364:1002-1008. 

  46. Park YC, Ko YD, Kim MK. Effects of estrogen, aging and oxidative stress on bone remodelling in a view of molecular mechanisms. J.Toxicol. Pub. Health. 2006;22(3):253-266. 

  47. Lee S, Maharjan S, Kim K, Kim MJ, Choi HJ, Kwon YJ, et al. Cholesterol-derived novel anti- apoptotic agents on the structural basis of ginsenoside Rk1, G.Q. Zhao, X.X. Wang, Chin. Trad. Herbal Drugs. 1986;17:34-43. 

  48. Kim YJ, Kwon HC, Ko H, Park JH, Kim HY, Yoo JH, et al.. Antitumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis. Biological & Pharmaceutical Bulletin. 2008;31:826-830. 

  49. Spencer PS, Roy DN, Ludolph A. Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet. 1986(2):1066-1067. 

  50. Hugon J, Ludolph AS, Spencer PS, Roldan S, Gimenez Dumas JL. Studies of the etiology and pathogenesis of motor neuron diseases. III. Magnetic cortical stimulation in patients with lathyrism, Acta Neurol. Scand. 1993;88:412-416. 

  51. Park H, Cho BG, Lee MK. Nitrogen Compounds of Korea Ginseng and Their Physiological Significance, Korean J. Ginseng Sci. 1990;14(2): 317-331. 

  52. Van Damme P, Van Den Bosch L, Van Houtte E, Callewaert G, Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity, J. Neurophysiol. 2002; 88:1279-1287. 

  53. Yano K, Higashida H, Inoue R, Nozawa Y. Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-bisphosphate in neuroblastoma X glioma hybrid NG108-15 cells, J. Biol. Chem. 1984;259:10201-10207. 

  54. Foskett JK, White C, Cheung KH, Mak DO. Inositol trisphosphate receptor Ca2+ release channels, Physiol. Rev. 2007;87:593-658. 

  55. Van MM, Decrock E, Coussee E, Faes L, Vuyst ED, Vranckx K, et al. l-ODAP alters mitochondrial Ca2+ handling as an early event in excitotoxicity. Cell Calcium. 2010;47:287-96. 

  56. Park YC. The molecular & biochemical pronciples of toxiciology. Korean Studies Information LTD. 2010;ISBN:978-89-268-1259-4. 

  57. Park YC, Lee SD. The Toxicokinetic Characteristics of Korean Traditional Medicines. The Korean journal of Oriental preventive medicien. 2011;15(2):1-19. 

  58. Lee NH, Gue SC. Systematic Review of Randomized Controlled Trials Evaluating the Efficacy and Safety of Ginseng. J Acupunct Meridian Stud. 2011;4(2):85-97. 

  59. Siegel RK. Ginseng abuse syndrome."Journal of the American Medical Association. 1979;241: 15-23. 

  60. Lee YJ, Chung E, Lee KY, Lee YH, Huh B, Lee SK. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng is a functional ligand of glucocorticoid receptor. Molecular and Cellular Endocrinology. 1997; 133:135-140. 

  61. Lee JY, Lim KM, Kim SY, Bae ON, Noh JY, Chung SM, et al. Vascular Smooth Muscle Dysfunction and Remodeling Induced by Ginsenoside Rg3. a Bioactive Component of Ginseng, Toxicoligical science. 2010;117(2); 505-514. 

  62. Hashimoto K, Satoh K, Murata P, Makino B, Sakakibara I, Kase Y, et al. Components of Panax ginseng that improve accelerated small intestinal transit, J. Ethnopharmacol. 2003;84:115-119. 

  63. Rudakewich M, Ba F, Benishin CG. Neurotrophic and neuroprotective actions of ginsenosides Rb(1) and Rg(1), Planta Med. 2001;67: 533-537. 

  64. Seely D, Dugoua JJ, Perri D, Mills E. Koren G. Safety and efficacy of panax ginseng during pregnancy and lactation. Can J Clin Pharmacol. 2008;15:e87-e94. 

  65. Sticher O. Saponine in Pharmakognosie, Phytopharmazie. Hansel R. & Sticher O. (eds.), Springer Verlag. Heidelberg. 2009;943-989. 

  66. MDidea. Exporting Division Extracts Professional. Available at:URL:www.MDidea.com. Access ed June 20, 2012. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로